ClinicalTrials.gg
CompletedNCT07884799Updated Oct 21, 2026

Postoperative Pain and Quality of Life Following Root Canal Treatment With Two Different Sealers

An interventional study of AH Plus and BioRoot Flow in Asymptomatic Apical Periodontitis, sponsored by Karadeniz Technical University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Karadeniz Technical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Apr 2026, registered Oct 2026).
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study compares two different root canal sealers, AH Plus and BioRoot Flow, to determine whether the type of sealer used during root canal treatment affects pain after treatment and oral health-related quality of life.

Root canal treatment is performed to treat infection inside a tooth. Some patients may experience pain or discomfort after treatment, which can affect their daily activities and well-being.

The study includes adults with asymptomatic apical periodontitis in a permanent tooth with one root and one root canal. Participants are randomly assigned to receive root canal treatment using either AH Plus, a resin-based sealer, or BioRoot Flow, a bioceramic-based sealer. All participants receive treatment in a single visit.

Pain after treatment is assessed using a visual analog scale at 6 and 12 hours and on days 1, 2, 3, 5, 7, and 30. Oral health-related quality of life is assessed using the 14-item Oral Health Impact Profile (OHIP-14) questionnaire on day 7. The study also evaluates pain medication use and swelling after treatment.

The findings may help clinicians better understand patients' experiences following root canal treatment with these two sealers.

Read the detailed description

Apical periodontitis is an inflammatory condition affecting the tissues surrounding the root of a tooth and is associated with infection of the root canal system. Root canal treatment aims to control the infection through cleaning, shaping, and irrigation of the root canal, followed by filling of the prepared canal.

Root canal sealers are used with gutta-percha to fill spaces between the root canal filling material and the canal walls. Sealers with different chemical compositions are available, including epoxy resin-based and calcium silicate-based bioceramic materials. Postoperative pain is an important patient-reported outcome following root canal treatment. In addition, oral health-related quality of life provides information about how oral health affects patients' daily functioning and well-being.

This randomized, parallel-group clinical study compares an epoxy resin-based root canal sealer (AH Plus) with a premixed bioceramic root canal sealer (BioRoot Flow) in patients with asymptomatic apical periodontitis affecting single-rooted, single-canal permanent teeth.

A total of 58 participants are included, with 29 participants allocated to each treatment group. Root canal treatment is completed in a single visit, and cold lateral condensation is used for root canal obturation in both groups. The type of root canal sealer differs between the groups.

Postoperative pain is assessed using a visual analog scale (VAS) at 6 and 12 hours and on days 1, 2, 3, 5, 7, and 30 after treatment. Oral health-related quality of life is evaluated using the Turkish version of the 14-item Oral Health Impact Profile (OHIP-14-TR) on day 7 after treatment. Additional assessments include postoperative analgesic consumption, the presence of swelling, and radiographic evaluation of the root canal filling in relation to the apical foramen.

The study aims to compare postoperative pain and oral health-related quality of life between the two sealer groups and to provide clinical information about patient-reported outcomes following single-visit root canal treatment.

02

Conditions studied

  • Asymptomatic Apical Periodontitis
03

In context

Lead sponsor

Karadeniz Technical University is the lead sponsor of 150 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Individuals without systemic diseases (ASA physical status I or II).

Individuals with single-rooted, single-canal permanent teeth requiring endodontic treatment.

Individuals with teeth diagnosed with asymptomatic apical periodontitis (2 ≤ PAI ≤ 4).

Exclusion criteria

Exclusion Criteria:

  • •Individuals with immature permanent teeth.

Individuals with previously root canal-treated teeth.

Individuals with systemic diseases.

Individuals with teeth exhibiting internal or external root resorption or a history of dental trauma.

Individuals who had taken analgesics within 24 hours before treatment.

Individuals with calcified root canals.

Individuals with symptomatic teeth.

Individuals with advanced periodontal disease.

Pregnant or breastfeeding individuals.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
58 participants (actual)

Study arms

  • Active comparator
    AH Plus

    Participants received single-visit root canal treatment using AH Plus, an epoxy resin-based root canal sealer, with the cold lateral condensation technique.

    Device: AH Plus

  • Experimental
    BioRoot Flow

    Participants received single-visit root canal treatment using BioRoot Flow, a bioceramic-based root canal sealer, with the cold lateral condensation technique.

    Device: BioRoot Flow

Interventions

  • DeviceAH Plus

    AH Plus, an epoxy resin-based root canal sealer, was used for root canal obturation in the control group. Root canal treatment was completed in a single visit, and obturation was performed using the cold lateral condensation technique with gutta-percha and AH Plus sealer

  • DeviceBioRoot Flow

    BioRoot Flow, a premixed calcium silicate-based bioceramic root canal sealer, was used for root canal obturation in the experimental group. Root canal treatment was completed in a single visit, and obturation was performed using the cold lateral condensation technique with gutta-percha and BioRoot Flow sealer.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity Assessed Using the Visual Analog Scale (VAS)

    Postoperative pain intensity was assessed using a 100-mm visual analog scale (VAS), ranging from 0 (no pain) to 100 (worst imaginable pain). Participants recorded their pain intensity at eight postoperative time points. Higher scores indicated greater pain intensity. VAS scores were compared between the AH Plus and BioRoot Flow groups.

    Time frame: 6 and 12 hours and 1, 2, 3, 5, 7, and 30 days after root canal treatment

  2. Oral Health-Related Quality of Life Assessed Using the OHIP-14

    Oral health-related quality of life was assessed using the Turkish version of the 14-item Oral Health Impact Profile (OHIP-14-TR) questionnaire. The questionnaire consists of 14 items across seven domains, with each item scored from 0 (never) to 4 (very often). Total scores range from 0 to 56, with higher scores indicating poorer oral health-related quality of life. OHIP-14 total scores were compared between the AH Plus and BioRoot Flow groups.

    Time frame: 7 days after root canal treatment

07

Study locations

1 site
  • Karadeniz Technical University Faculty of Dentistry
    Trabzon, Ortahisar, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2026 to primary completion in Jun 2026, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2026
First posted
Oct 21, 2026
StartActual
Apr 1, 2026
Primary completionActual
Jun 1, 2026
CompletionActual
Jun 1, 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07884799
Responsible party
Nihan Çelik Uzun (ASSİSTANT PROFESSOR, Karadeniz Technical University) — Principal investigator
First posted
Oct 21, 2026
Start date
Apr 1, 2026
Primary completion
Jun 1, 2026
Completion
Jun 1, 2026
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion